About us

Our vision

Our vision is to offer better protection to patients during acute, severe and life-threatening medical conditions by an effective, user-friendly, safe and immediately active powder-based Intranasal specialized products.

Management

Dan Teleman, CEO

Chief Executive Officer

Dr. Dalia Megiddo

Co-founder, Board Member & Chief Development Officer

Tair Lapidot, Ph.D

VP R&D AND CLINICAL DEVELOPMENT

Galia Temtsin Kryaz, Ph.D.

Director of Product Development

Oren Elmaliah

DIrector of Finance

Board of Directors

Isaac Israel

Director

Dr. Sharon Shacham

Director

David Silberman

Director

Udi Gilboa

Co-Founder & Executive Chairman

Dr. Dalia Megiddo

Co-founder, Board Member & Chief Development Officer

Dr. Ronnie Hershman

Board Member

Team Members

Galia Temtsin Kryaz, Ph.D.

Director of Product Development

Tair Lapidot, Ph.D

VP R&D and Clinical Development

Carolina Abrutzky

VP CMC

Oren Elmaliah

Director of Finance

Iris Erez

Commercial & Marketing Director

MIQUEL MARTI JUVANTENY

Director of Business Development

Ayelet Rahav

Senior Director of RA & QA

Advisory Board

Prof Yuval Tal

Prof Regina Scherließ

David M. Fleischer, MD

Jonathan Bernstein, MD

Our story

Nasus pharma brings the new frontier in Intranasal drug delivery. Late-Stage Specialty Pharma company, offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats.